'Ecstasy'-induced subarachnoid haemorrhage: an under-reported neurological complication?
Gabriel Yin Foo Lee, Grace Wooi Kee Gong, Nikitas Vrodos, Brian Patrick Brophy
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia November 2003 DOI: 10.1016/s0967-5868(03)00151-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 2 |
| Population | Young patients who ingested Ecstasy tablets and suffered subarachnoid haemorrhage |
| Topics | MDMA |
| Key findings | Both patients showed angiographic features consistent with vasculitis following MDMA ingestion, suggesting a possible association between Ecstasy use and subarachnoid haemorrhage. |
Abstract
In the face of escalating recreational use of 'Ecstasy' (3,4-methylenedioxymethamphetamine, MDMA), physicians need to be aware of its possible adverse effects. We report two young patients who suffered subarachnoid haemorrhage following ingestion of 'Ecstasy' tablets. Angiographic studies demonstrated features consistent with vasculitis in both cases. Recognition of this association is important and highlights the significance of eliciting a careful drug history, particularly in cases of 'angiogram negative' subarachnoid haemorrhage.